S 1126 116th Congress Senate Health Aging Health care coverage and access Health care quality Health information and medical records Health promotion and preventive care Health technology, devices, supplies Medical research Medical tests and diagnostic methods Medicare Neurological disorders

Concentrating on High-value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2019

Introduced: April 10, 2019 Introduced by: Capito, Shelley Moore Republican · West Virginia See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Apr 10, 2019

Read twice and referred to the Committee on Finance.

Apr 10, 2019

Introduced in Senate

Plain-English summary Congressional Research Service

Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019

This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports.

Additionally, the Centers for Medicare and Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.

What's happening now April 10, 2019

Read twice and referred to the Committee on Finance.

Committees of jurisdiction 1